SCHEMBL24565746

SCHEMBL24565746

N#CN[C@H]1[C@@H]2CN(C(=O)c3csc(-c4ccc(Cl)cc4Cl)n3)C[C@@H]21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 1/20 0.47
PRKCG P05129 1/20 0.47
PRKCB P05771 1/20 0.47
IL1R1 P14778 1/20 0.47
PRKCA P17252 1/20 0.47
TNFRSF1A P19438 1/20 0.47
PRKCH P24723 1/20 0.47
PRKCI P41743 1/20 0.47
PRKCE Q02156 1/20 0.47
PRKCQ Q04759 1/20 0.47
PRKCZ Q05513 1/20 0.47
PRKCD Q05655 1/20 0.47
PRKD1 Q15139 1/20 0.47
TLR7 Q9NYK1 1/20 0.47
HTR2C P28335 7/20 0.43
SHMT1 P34896 6/20 0.41
SHMT2 P34897 5/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22494622 0.84 HTR2C (0.50) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL24565742 0.83 PRKD3 (0.46) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL24565448 0.80 PRKD3 (0.46) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL24565737 0.78 HTR2C (0.44) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL24565761 0.77 KMT2A (0.43) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL22637331 0.76 HTR2C (0.46) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL24565484 0.76 PRKD3 (0.41) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL22644745 0.72 PRKD3 (0.43) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL22637425 0.71 HTR2C (0.51) PRKD3PRKCGPRKCBIL1R1PRKCA
SCHEMBL22637423 0.71 HTR2C (0.51) PRKD3PRKCGPRKCBIL1R1PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204495-A1 INHIBITING TRABID Valo Health, LLC 2022-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204495-A1 INHIBITING TRABID TPO, PRKACG, NFKBIA PRKD3 114/4885PRKCG 374/4885PRKCB 335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.